A nanopore membrane regulator device for laser modulated flow after glaucoma surgery

Verfasser / Beitragende:
[Jeffrey Olson, Ramanath Bhandari, Sergio Groman-Lupa, Raul Velez-Montoya]
Ort, Verlag, Jahr:
2015
Enthalten in:
Biomedical Microdevices, 17/5(2015-10-01), 1-6
Format:
Artikel (online)
ID: 605480087
LEADER caa a22 4500
001 605480087
003 CHVBK
005 20210128100413.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s10544-015-9985-2  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10544-015-9985-2 
245 0 2 |a A nanopore membrane regulator device for laser modulated flow after glaucoma surgery  |h [Elektronische Daten]  |c [Jeffrey Olson, Ramanath Bhandari, Sergio Groman-Lupa, Raul Velez-Montoya] 
520 3 |a Glaucoma, the second most common cause of blindness in the world, is a multifactorial disease with several risk factors, of which intraocular pressure (IOP) is a primary contributing factor. Filtration surgery is one of the most effective means to significantly lower IOP compared to medical or laser treatments, and it is typically reserved for advanced disease. However, there are high rates of postoperative complications associated with the procedure, often from over- or under-filtration. To address these problems, the glaucoma drainage device regulator (GDDR) implant was developed to allow post-operative control of aqueous flow and IOP. The device, a tube with a nanopore membrane, is placed beneath the scleral flap. Postoperatively, the membrane surface can be ruptured with a laser to augment flow through the system. This feature allows adjustable control of aqueous flow and diminishes the risk of hypotony in the early postoperative period. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Glaucoma drainage device  |2 nationallicence 
690 7 |a Intraocular pressure  |2 nationallicence 
690 7 |a Aqueous flow  |2 nationallicence 
700 1 |a Olson  |D Jeffrey  |u Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, 1675 Aurora Court, 80045, Aurora, CO, USA  |4 aut 
700 1 |a Bhandari  |D Ramanath  |u Department of Ophthalmology, Springfield Clinic, Springfield, IL, USA  |4 aut 
700 1 |a Groman-Lupa  |D Sergio  |u Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, 1675 Aurora Court, 80045, Aurora, CO, USA  |4 aut 
700 1 |a Velez-Montoya  |D Raul  |u Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, 1675 Aurora Court, 80045, Aurora, CO, USA  |4 aut 
773 0 |t Biomedical Microdevices  |d Springer US; http://www.springer-ny.com  |g 17/5(2015-10-01), 1-6  |x 1387-2176  |q 17:5<1  |1 2015  |2 17  |o 10544 
856 4 0 |u https://doi.org/10.1007/s10544-015-9985-2  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10544-015-9985-2  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Olson  |D Jeffrey  |u Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, 1675 Aurora Court, 80045, Aurora, CO, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bhandari  |D Ramanath  |u Department of Ophthalmology, Springfield Clinic, Springfield, IL, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Groman-Lupa  |D Sergio  |u Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, 1675 Aurora Court, 80045, Aurora, CO, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Velez-Montoya  |D Raul  |u Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, 1675 Aurora Court, 80045, Aurora, CO, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Biomedical Microdevices  |d Springer US; http://www.springer-ny.com  |g 17/5(2015-10-01), 1-6  |x 1387-2176  |q 17:5<1  |1 2015  |2 17  |o 10544